Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001031803 | SCV001195109 | pathogenic | Ataxia-telangiectasia syndrome | 2019-10-18 | criteria provided, single submitter | clinical testing | This variant is an out-of-frame deletion of the genomic region encompassing exon 9 of the ATM gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. Deletion of exon 9 has not been reported in the literature in individuals with ATM-related disease. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). For these reasons, this variant has been classified as Pathogenic. |